Navigation Links
Clinical Trial First to Test Heart Drug Regimen for Duchenne Muscular Dystrophy
Date:6/26/2012

CINCINNATI, June 26, 2012  /PRNewswire-USNewswire/ -- The first landmark randomized clinical trial for a cardiac drug regimen in Duchenne muscular dystrophy (DMD) is testing whether earlier treatment can stop or slow down heart damage that usually kills people with the disease.

(Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO)

The study is a collaboration of Cincinnati Children's Hospital Medical Center, Ohio State University (OSU) and The Christ Hospital in Cincinnati.

Extensive research – including studies in mouse models of DMD – suggests an anti-fibrosis drug long used to treat heart attack victims, eplerenone, could help people with the disease, said Kan Hor, MD, a principal investigator and a physician/researcher at Cincinnati Children's.

Disease-associated heart damage is the leading cause of death in patients between ages 20 and 30 – the maximum life span for people with DMD.

A key element of the new treatment approach is using enhanced cardiac magnetic resonance imaging, Hor said. The technique – more sensitive than standard echocardiogram tests now used in DMD – is designed to catch minute declines in heart function much earlier in a child's life.

"Standard diagnostic techniques rarely catch significant heart damage in DMD in the first decade, although research shows scar tissue is already developing in many patients before it's clinically detectable through current methods," said Hor, who works in the Cincinnati Children's Heart Institute. "We want to determine the optimal time point to detect these early changes in heart function and start cardiac therapy with anti-fibrotic medication." 

A genetic disease that affects mostly boys, DMD is the most common form of muscular dystrophy. Most children begin losing the ability to walk between the ages of 7 and 13. With decades of res
'/>"/>

SOURCE Cincinnati Children's Hospital Medical Center
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
2. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
3. Clinical Site Services Is Bringing 3x More Patient Enrollment to the 48th Annual DIA Meeting
4. Effectiveness of Medicare Authorization Program for Power Wheelchairs Rests on Inclusion of a Clinical Template
5. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
6. Sentry BioPharma Services Invests in Global Clinical Supply Services with -45C Freezer Expansion
7. New Report Shows Ohio Clinical Trials Benefit Patients, the Economy and Science
8. Clinical Safety Data for ChromaDex®s Patented pTeroPure® (pterostilbene) Released at 6th World Congress on Polyphenols Applications in Paris
9. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
10. Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research
11. Pycnogenol® (French Maritime Pine Bark Extract) Shown To Improve Endothelial Function And Reduce Oxidative Stress In New Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation ... of directors has approved a quarterly dividend of $0.275 (27.5 ... is payable on August 1, 2014, to holders of record ... CVS Caremark is dedicated to helping people on ... company in the United States . Through ...
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... 2014 Massachusetts General Hospital (MGH), the Broad ... announced today that they have launched a strategic ... targets and develop novel therapies for inflammatory bowel ... worldwide. The MGH-Broad-Amgen collaboration brings together scientists with ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... , , JERUSALEM , ... Dr. Amatruda is the Former Senior Vice President and Franchise Head of,the ... Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB; http://www.oramed.com ), a,developer of oral ... Oramed,s Scientific Advisory Board, enhancing Oramed,s,talented and experienced scientific team. , ...
... , , MOUNTAIN VIEW, Calif. ... ) announced today that it will host an investor/analyst meeting on ... ET , in New York City . , The meeting will ... CEO, Alexza Pharmaceuticals James Cassella , PhD - ...
Cached Medicine Technology:Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 2Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4
(Date:7/11/2014)... Riverside Health System became the first provider of ... 2012 and now, in partnership with Williamsburg Landing, will offer ... and Newport News region. , Also known as life care ... older adults who wish to remain in their homes but ... care services as well as control over the cost of ...
(Date:7/11/2014)... Pigments are insoluble colorants, which usually consist of ... coating, opacity, and coloring. These are water and oil ... substances such as paper, paints, plastics, and concrete. Binders ... impart color to the substance. Some examples of pigments ... , The coloring action of pigments is due to ...
(Date:7/11/2014)... Riviera Maya, Mexico (PRWEB) July 11, 2014 ... Mexico with the Mayan Heritage Experience Package at the ... Highlights of the package include a guided on-site ecological ... fauna, as well as The Coba Mayan Encounter Tour ... also climb Nohoch Muul, the tallest pyramid in the ...
(Date:7/11/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer ... prom dresses . To bring more benefits to worldwide clients ... a special offer for these brand new items. Clients can ... company’s sales manager says gladly, “We are happy to announce ... to acknowledge all new and old customers and strengthen our ...
(Date:7/11/2014)... that people who have grown up on a farm ... urban counterparts to develop the most common inflammatory bowel ... have recently been published in the European Journal ... we can now see that not only allergic diseases, ... on the environment we are exposed to early in ...
Breaking Medicine News(10 mins):Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 2Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 3Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 3Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2
... use of complementary and alternative medicine (CAM) in over 2000 ... from acupuncture to yoga - has increased in popularity since ... medicine has always been popular, although the type of therapies ... ,The greatest increase in popularity was in the transition ...
... found a cheap and non toxic method of treating Hepatitis, ... virus infects the liver, and in severe cases can lead ... through contact with the blood or body fluids of an ... HBV after a very bright and aware patient observed that ...
... gives powerful relief for chronic pain, and should be ... told a conference in Glasgow.,Dr William Notcutt of the ... cannabis extract used in his study - applied as ... in easing chronic pain. He announced the findings at ...
... Both drugs and surgery may be effective in treating Meniere's ... the hearing apparatus. A build up of pressure causes vertigo ... leads to hearing loss in the affected ear, and the ... ,This disease has a wide range of treatments available.Many ...
... form of arterial disease appear to have low levels of ... smoking habits. ,Peripheral artery disease (PAD) is a form of ... arteries and obstructs blood flow. In PAD, blood flow in ... and pain. PAD is also associated with an increased risk ...
... the number of miles you fly affects your risk of ... increase the risk of blood clotting in the veins of ... breaks off, it may travel to the lungs, forming a ... ,Researchers in France and the US have monitored all ...
Cached Medicine News:
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. Designated most popular model or size....
Designated most popular model or size. Double-ended. 2 mm wide....
Desmarres Retractor Size 4...
Medicine Products: